Mechanism of the paradoxical, inhibitory effect of phenobarbital on hepatocarcinogenesis initiated in infant B6C3F1 mice with diethylnitrosamine

Cancer Research

Volumn 58, Issue 8, 1998, Pages 1665-1669

  Lee, Gang Hong ^a   Ooasa, Takao ^a   Osanai, Makoto ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLNITROSAMINE; PHENOBARBITAL;

ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIVER CANCER; LIVER CARCINOGENESIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEREOMETRY;

ADENOMA; ANIMALS; ANIMALS, NEWBORN; ANTICARCINOGENIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL DIVISION; DIETHYLNITROSAMINE; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; PHENOBARBITAL; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0032522458     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Peraino, C., Fry, R. J. M., and Staffeldt, E. Reduction and enhancement by phenobarbital of hepatocarcinogenesis induced in the rat by 2-acetylaminofluorene. Cancer Res., 31: 1506-1512, 1971.
2. Moore, M. A., and Kitagawa, T. Hepatocarcinogenesis in the rat: the effect of promotors and carcinogens in vivo and in vitro. Int. Rev. Cytol., 101: 125-173, 1986.
3. 1 mice. Carcinogenesis (Lond.), 4: 1021-1029, 1983.
4. Diwan, B. A., Rice, J. M., Ohshima, M., and Ward, J. M. Interstrain difference in susceptibility to liver Carcinogenesis initiated by N-nitrosodiethylamine and its promotion by phenobarbital in C57BL/6NCr. C3H/HeNCr and DBA/2NCr mice. Carcinogenesis (Lond.). 7: 215-220, 1986.
5. Lee, G-H., Nomura, K., and Kitagawa, T. Comparative study of diethylnitrosamine-initiated two-stage hepatocarcinogenesis in C3H, C57BL and BALB mice promoted by various hepatopromoters. Carcinogenesis (Lond.), 10: 2227-2230, 1989.
6. Lee, G-H. Correlation between Bcl-2 expression and histopathology in diethylnitrosamine-induced mouse hepatocellular tumors. Am. J. Pathol., 151: 957-962, 1997.
7. Mills, J. J., Jirtle, R. L., and Boyer, I. J. Mechanisms of liver tumor promotion. In: R. L. Jirtle (ed.), Liver Regeneration and Carcinogenesis, pp. 199-226. San Diego, CA: Academic Press, Inc., 1995.
8. Schulte-Hermann, R., Grasl-Kraupp, B., and Bursch, W. Apoptosis and hepatocarcinogenesis. In: R. L. Jirtle (ed.), Liver Regeneration and Carcinogenesis, pp. 179-197. San Diego, CA: Academic Press, Inc., 1995.
9. Tsujimoto, Y., Cossman, J., Jaffe, E., and Croce, C. M. Involvement of the bcl-2 gene in human follicular lymphoma. Science (Washington DC), 228: 1440-1443, 1985.
10. Vaux, D. L., Corg, S., and Adams, J. M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature (Lond.), 335: 440-442, 1988.
11. Reed, J. C. Bcl-2 and the regulation of programmed cell death. J. Cell Biol., 124: 1-6, 1994.
12. 1 mice. Cancer Lett., 23: 223-234, 1984.
13. Pereira, M. A., Klaunig, J. E., Herren-Freund, S. L., and Ruch, R. J. Effect of phenobarbital on the development of liver tumors in juvenile and adult mice. J. Natl. Cancer Inst., 77: 449-452, 1986.
14. Naito, M., Naito, Y., and Ito, A. Effect of phenobarbital on the development of tumors in mice treated neonatally with N-ethyl-N-nitrosourea. Gann. 73: 111-114, 1982.
15. Osanai, M., Ogawa, K., and Lee, G-H. Phenobarbital causes apoptosis in conditionally immortalized mouse hepatocytes depending on deregulated c-myc expression: characterization of an unexpected effect. Cancer Res., 57: 2896-2903, 1997.
16. Worner, W., and Schrenk, D. Influence of liver tumor promoters on apoptosis in rat hepatocytes induced by 2-acetylaminofluorene, ultraviolet light, or transforming growth factor β1. Cancer Res., 56: 1272-1278, 1996.
17. Doull, J. The mouse in safety evaluation. Arch. Toxicol., 10 (Suppl.): 3-9, 1987.
18. Vesselinovitch, S. D., and Mihailovich, N. Kinetics of diethylnitrosamine hepatocarcinogenesis in the infant mouse. Cancer Res., 43: 4253-4259, 1983.
19. Frith, C. H., and Ward, J. M. A morphologic classification of proliferative and neoplastic hepatic lesions in mice. J. Environ. Pathol. Toxicol., 3: 329-351, 1979.
20. Enzmann, H., Edler, L., and Bannasch, P. Simple elementary method for the quantification of focal liver lesions induced by carcinogens. Carcinogenesis (Lond.), 8: 231-235, 1987.
21. Dietrich, D. R. Toxicological and pathological applications of proliferating cell nuclear antigen (PCNA), a novel endogenous marker for cell proliferation. Crit. Rev. Toxicol., 23: 77-109, 1993.
22. Bursch, W., Taper, H. S., Lauer, B., and Schulte-Hermann, R. Quantitative histological and histochemical studies on the occurrence and stages of controlled cell death (apoptosis) during regression of rat liver hyperplasia. Virchows Arch. B Cell Pathol., 50: 153-166, 1985.
23. Moore, M. R., Drinkwater, N. R., Miller, E. C., Miller, J. A., and Pitot, H. C. Quantitative analysis of the time-dependent development of glucose-6-phosphatase-deficient foci in the livers of mice treated neonatally with diethylnitrosamine. Cancer Res., 41: 1585-1593, 1981.
24. Pedrick, M. S., Rumsby, P. C., Wright, V., Phillimore, H. E., Butler, W. H., and Evans, J. G. Growth characteristics and Ha-ras mutations of cell cultures isolated from chemically induced mouse liver tumours. Carcinogenesis (Lond.), 15: 1847-1852, 1994.
25. Rumsby, P. C., Barrass, N. C., Phillimore, H. E., and Evans, J. G. Analysis of the Ha-ras oncogene in C3H/He mouse liver tumours derived spontaneously or induced with diethylnitrosamine or phenobarbitone. Carcinogenesis (Lond.), 12: 2331-2336, 1991.
26. Manjeshwar, S., Laconi, E., Sheikh, A., Rao, P. M., Rajalakshmi, S., and Sarma, D. S. In vitro and in vivo response of hepatocytes from hepatic nodules to the mitoinhibitory effects of phenobarbital. Carcinogenesis (Lond.), 15: 1963-1968, 1994.
27. Rissler, P., Torndal, U. B., and Eriksson, L. C. Induced drug resistance inhibits selection of initiated cells and cancer development. Carcinogenesis (Lond.), 18: 649-655, 1997.
28. Allen, P. T., and Poirier, L. A. Suppression by phenobarbital of ethionine-induced hepatocellular carcinoma formation and hepatic S-adenosylethionine levels. Carcinogenesis (Lond.), 18: 1103-1107, 1997.
29. Post, J., and Hoffman, J. Changes in the replication times and patterns of the liver cells during the life of the rat. Exp. Cell Res., 36: 111-123, 1964.
30. Dragani, T. A., Manenti, G., Porta, G. D., Gattoni-Celli, S., and Weinstein, I. B. Expression of retroviral sequences and oncogenes in murine hepatocellular tumors. Cancer Res., 46: 1915-1919, 1986.
31. Pitot, H. C., and Sirica, A. E. The stages of initiation and promotion in hepatocarcinogenesis. Biochim. Biophys. Acta, 605: 191-215, 1980.
32. Kitagawa, T., Nomura, K., and Sasaki, S. Induction by X-irradiation of adenosine triphosphatase-deficient islands in the rat liver and their characterization. Cancer Res., 45: 6078-6082, 1985.
33. Rao, M. S., Tatematsu, M., Subbarao, V., Ito, N., and Reddy, J. K. Analysis of peroxisome proliferator-induced preneoplastic and neoplastic lesions of rat liver for placental form of glutathione S-transferase and γ-glutamyl transpeptidase. Cancer Res., 46: 5287-5290, 1986.